Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Abaloparatide for Sale > Abaloparatide CAS NO.247062-33-5, 98%+ Purity Peptide
Abaloparatide CAS NO.247062-33-5, 98%+ Purity Peptide buy - large image1
Abaloparatide CAS NO.247062-33-5, 98%+ Purity Peptide buy - image1
Abaloparatide CAS NO.247062-33-5, 98%+ Purity Peptide buy - image2
Abaloparatide CAS NO.247062-33-5, 98%+ Purity Peptide buy - image3
Abaloparatide CAS NO.247062-33-5, 98%+ Purity Peptide buy - image4
Abaloparatide CAS NO.247062-33-5, 98%+ Purity Peptide buy - image5
Abaloparatide CAS NO.247062-33-5, 98%+ Purity Peptide buy - image6

Abaloparatide CAS NO.247062-33-5, 98%+ Purity Peptide

110 Inquiries

Unit Price: Get Latest Price
CAS No.:

247062-33-5

Port:

tianjin

Packaging:

25kg/bag

Price valid (until):

2026-10-14

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
5 days
Qualification:
Main Products:

Food Additives

  • Product Details

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Shop Abaloparatide CAS NO.247062-33-5, 98%+ Purity Peptide-Detailed Image 1

    Product Name: Abaloparatide

    CAS No: 247062-33-5

    Purity: ≥98% (HPLC)

    Appearance: White to off-white amorphous powder

    Properties: This peptide compound is hygroscopic. It is soluble in dilute aqueous acid, slightly soluble in some organic solvents.

    Recommended Storage Condition: Store at -20°C in sealed container, protected from light and moisture.

    Application: For laboratory research use only. Not for human or animal clinical use, not for pharmaceutical formulation.

    Packaging: Available in small lab packaging, such as 1g, 2g, 5g.

    COA: Certificate of Analysis can be provided upon request, including HPLC, water content and other test items.

    Remarks: The product is only supplied for scientific research. End users shall take responsibility for compliance with local import regulations.

    ECHEMI Editorial Reference
    Abaloparatide is a parathyroid hormone receptor 1 (PTHR1) analog and a selective PTHR1 activator. Abaloparatide enhances Gs/cAMP signaling and β-arrestin recruitment. Abaloparatide enhances bone formation and cortical structure in mice. Abaloparatide is used to treat osteoporosis.
    Research & Reference Note

    Abaloparatide CAS NO.247062-33-5, 98%+ Purity Peptide is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

    Disclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

    Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals

    Basic Info
    Product Name:

    Abaloparatide

    Other Name:

    Abaloparatide;Abaloparatide (BA058)

    CAS No.:

    247062-33-5

    Molecular Formula:

    C174H300N56O49

    InChIKeys:

    BVISQZFBLRSESR-XSCWXTNMSA-N

    Molecular Weight:

    3960.5896

    EC Number:

    218-362-5

    Color/Form:

    White to off-white

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Food Additives

    Location:

    Room 2-5633, Building A, No.6 Huafeng Road, Huaming High-tech Industrial Zone, Dongli District, Tianjin

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    5 days

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    201-300

    Year of Establishment:

    2022

  • Inquiry History
    110 Inquiries
    Country Product Purchase Quantity Date Posted
    Australia

    Abaloparatide

    30 MG Oct 27, 2026
    United States

    Abaloparatide

    0.1 G Oct 28, 2026
    Germany

    Abaloparatide

    500 MG Oct 26, 2026
    Costa Rica

    Abaloparatide

    30 MG Oct 22, 2026
    United States

    abaloparatide

    10 MG Oct 22, 2026
    United States

    Abaloparatide

    4 MT Oct 21, 2026
    United States

    Abaloparatide

    500 G Oct 21, 2026
    Costa Rica

    Abaloparatide

    5  Oct 17, 2026
    Russia

    Abaloparatide

    3 MG Oct 13, 2026
    United States

    Abaloparatide

    30 MG Oct 12, 2026
    Kazakstan

    Abaloparatide

    10 MG Oct 12, 2026
    United States

    Abaloparatide

    100 MG Oct 11, 2026
    Germany

    Abaloparatide

    100 MG Oct 9, 2026
    China

    Abaloparatide

    10 MT Oct 8, 2026
    Greece

    Abaloparatide

    10 MG Oct 6, 2026
    Hungary

    Abaloparatide

    30 MG Oct 2, 2026
    Canada

    Abaloparatide

    30 MG Oct 2, 2026
    Hungary

    Abaloparatide

    30 MG Oct 2, 2026
    Germany

    Abaloparatide

    5 MG Oct 1, 2026
    Germany

    Abaloparatide

    60 MG Sep 27, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.